Boehringer Ingelheim plans to double Romanian market share

By the end of last year, the company ranked 28th among top pharmaceutical companies operating on the local market, according to Cegedim research company.

The company’s strategy includes increasing the number of employees and launching new cardiovascular drugs.

Last year, the company’s net sales amounted to €22.4 million (based on pharmacy prices).

The local pharmaceutical market was worth €1.85 billion in 2007, with GlaxoSmithKline market leader, followed by Hoffmann La Roche and Sanofi Aventis.